Mercer Global Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.8M Sell
141,502
-2,855
-2% -$1.02M 0.07% 156
2025
Q4
$46.7M Buy
144,357
+23,179
+19% +$7.35M 0.07% 173
2025
Q3
$34.2M Buy
121,178
+5,691
+5% +$1.65M 0.06% 203
2025
Q2
$32.3M Sell
115,487
-4,949
-4% -$1.4M 0.07% 167
2025
Q1
$37.5M Buy
120,436
+3,899
+3% +$1.15M 0.09% 135
2024
Q4
$30.4M Buy
+116,537
New +$34.6M 0.07% 145
2024
Q1
Sell
-242,275
Closed -$69.8M 1973
2023
Q4
$69.8M Buy
242,275
+147,181
+155% +$40.1M 0.21% 76
2023
Q3
$25.6M Buy
95,094
+2,391
+3% +$597K 0.1% 130
2023
Q2
$20.6M Buy
92,703
+6,772
+8% +$1.57M 0.08% 169
2023
Q1
$20.8M Buy
85,931
+4,933
+6% +$1.21M 0.09% 160
2022
Q4
$21.3M Buy
80,998
+3,687
+5% +$988K 0.11% 155
2022
Q3
$17.4M Buy
77,311
+5,843
+8% +$1.42M 0.1% 154
2022
Q2
$17.4M Buy
71,468
+9,208
+15% +$2.26M 0.11% 151
2022
Q1
$15.1M Buy
62,260
+7,379
+13% +$1.7M 0.09% 169
2021
Q4
$12.3M Sell
54,881
-6,714
-11% -$1.42M 0.08% 190
2021
Q3
$13.1M Buy
61,595
+8,868
+17% +$2.04M 0.09% 180
2021
Q2
$12.9M Sell
52,727
-4,036
-7% -$993K 0.1% 161
2021
Q1
$14.1M Buy
56,763
+9,091
+19% +$2.17M 0.13% 128
2020
Q4
$11M Buy
47,672
+1,716
+4% +$396K 0.14% 113
2020
Q3
$11.7M Buy
45,956
+1,250
+3% +$310K 0.18% 92
2020
Q2
$10.5M Buy
44,706
+2,717
+6% +$620K 0.19% 78
2020
Q1
$8.51M Buy
41,989
+4,383
+12% +$957K 0.19% 102
2019
Q4
$9.07M Buy
37,606
+8,100
+27% +$1.79M 0.18% 106
2019
Q3
$5.71M Buy
29,506
+9,605
+48% +$1.84M 0.13% 137
2019
Q2
$3.67M Buy
19,901
+575
+3% +$103K 0.1% 174
2019
Q1
$3.67M Buy
+19,326
New +$3.69M 0.13% 144

Other funds holding AMGN

Mercer Global Advisors's AMGN Position: Q1 2026 in Review

Mercer Global Advisors reduced its Amgen (AMGN) stake by 2% in Q1 2026, selling an estimated $1.02M and leaving 141,502 shares worth $49.8M. The position accounts for 0.07% of the portfolio, ranked #156.

Mercer Global Advisors first reported a position in AMGN in Q1 2019 and has held it in 26 quarters since. The position peaked at $69.8M in Q4 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mercer Global Advisors held 141,502 shares of Amgen worth $49.8M as of Q1 2026.
  • Mercer Global Advisors sold 2,855 Amgen shares in Q1 2026, an estimated $1.02M.
  • Amgen made up 0.07% of Mercer Global Advisors's portfolio in Q1 2026, its #156 holding.
  • Mercer Global Advisors first reported a position in Amgen in Q1 2019 and has held it in 26 quarters since.
  • Mercer Global Advisors's Amgen position peaked at $69.8M in Q4 2023.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.